Annual CFO
-$7.31 M
+$5.19 M+41.52%
December 31, 2023
Summary
- As of February 7, 2025, ENTX annual cash flow from operations is -$7.31 million, with the most recent change of +$5.19 million (+41.52%) on December 31, 2023.
- During the last 3 years, ENTX annual CFO has risen by +$3.25 million (+30.76%).
- ENTX annual CFO is now -132.65% below its all-time high of -$3.14 million, reached on December 31, 2016.
Performance
ENTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.15 M
-$819.00 K-61.35%
September 30, 2024
Summary
- As of February 7, 2025, ENTX quarterly cash flow from operations is -$2.15 million, with the most recent change of -$819.00 thousand (-61.35%) on September 30, 2024.
- Over the past year, ENTX quarterly CFO has dropped by -$292.00 thousand (-15.68%).
- ENTX quarterly CFO is now -61.35% below its all-time high of -$1.33 million, reached on June 30, 2024.
Performance
ENTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.97 M
-$629.00 K-8.57%
September 30, 2024
Summary
- As of February 7, 2025, ENTX TTM cash flow from operations is -$7.97 million, with the most recent change of -$629.00 thousand (-8.57%) on September 30, 2024.
- Over the past year, ENTX TTM CFO has dropped by -$405.00 thousand (-5.36%).
- ENTX TTM CFO is now -222.98% below its all-time high of -$2.47 million, reached on March 31, 2018.
Performance
ENTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ENTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.5% | -15.7% | -5.4% |
| 3 y3 years | +30.8% | -38.2% | +1.0% |
| 5 y5 years | +25.4% | -38.2% | +1.0% |
ENTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.5% | -61.4% | +55.0% | -18.9% | +38.7% |
| 5 y | 5-year | at high | +41.5% | -61.4% | +55.0% | -18.9% | +38.7% |
| alltime | all time | -132.7% | +41.5% | -61.4% | +55.0% | -223.0% | +38.7% |
Entera Bio Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.15 M(+61.3%) | -$7.97 M(+8.6%) |
| Jun 2024 | - | -$1.33 M(-28.3%) | -$7.34 M(-3.0%) |
| Mar 2024 | - | -$1.86 M(-28.8%) | -$7.56 M(+3.5%) |
| Dec 2023 | -$7.31 M(-41.5%) | -$2.62 M(+71.6%) | -$7.31 M(+9.0%) |
| Sep 2023 | - | -$1.52 M(-2.2%) | -$6.70 M(-16.7%) |
| Jun 2023 | - | -$1.56 M(-3.1%) | -$8.05 M(-13.6%) |
| Mar 2023 | - | -$1.61 M(-20.0%) | -$9.32 M(-25.5%) |
| Dec 2022 | -$12.50 M(+37.9%) | -$2.01 M(-29.9%) | -$12.50 M(-3.9%) |
| Sep 2022 | - | -$2.87 M(+1.5%) | -$13.00 M(+6.2%) |
| Jun 2022 | - | -$2.83 M(-41.0%) | -$12.24 M(+6.1%) |
| Mar 2022 | - | -$4.79 M(+90.8%) | -$11.53 M(+27.3%) |
| Dec 2021 | -$9.06 M(-14.2%) | -$2.51 M(+19.1%) | -$9.06 M(+12.2%) |
| Sep 2021 | - | -$2.11 M(-0.6%) | -$8.08 M(-8.4%) |
| Jun 2021 | - | -$2.12 M(-8.6%) | -$8.82 M(-13.7%) |
| Mar 2021 | - | -$2.32 M(+52.0%) | -$10.22 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$10.56 M(+18.4%) | -$1.53 M(-46.4%) | -$10.56 M(-13.7%) |
| Sep 2020 | - | -$2.85 M(-19.2%) | -$12.23 M(+10.8%) |
| Jun 2020 | - | -$3.53 M(+32.8%) | -$11.04 M(+14.5%) |
| Mar 2020 | - | -$2.66 M(-17.1%) | -$9.64 M(+8.1%) |
| Dec 2019 | -$8.92 M(-9.0%) | -$3.20 M(+93.2%) | -$8.92 M(+10.6%) |
| Sep 2019 | - | -$1.66 M(-21.9%) | -$8.07 M(-6.7%) |
| Jun 2019 | - | -$2.12 M(+9.9%) | -$8.65 M(-6.7%) |
| Mar 2019 | - | -$1.93 M(-17.8%) | -$9.26 M(-5.5%) |
| Dec 2018 | -$9.80 M(+116.4%) | -$2.35 M(+5.1%) | -$9.80 M(+31.6%) |
| Sep 2018 | - | -$2.24 M(-18.4%) | -$7.44 M(+43.0%) |
| Jun 2018 | - | -$2.74 M(+11.1%) | -$5.21 M(+111.1%) |
| Mar 2018 | - | -$2.47 M | -$2.47 M |
| Dec 2017 | -$4.53 M(+44.0%) | - | - |
| Dec 2016 | -$3.14 M(-10.1%) | - | - |
| Dec 2015 | -$3.50 M | - | - |
FAQ
- What is Entera Bio annual cash flow from operations?
- What is the all time high annual CFO for Entera Bio?
- What is Entera Bio annual CFO year-on-year change?
- What is Entera Bio quarterly cash flow from operations?
- What is the all time high quarterly CFO for Entera Bio?
- What is Entera Bio quarterly CFO year-on-year change?
- What is Entera Bio TTM cash flow from operations?
- What is the all time high TTM CFO for Entera Bio?
- What is Entera Bio TTM CFO year-on-year change?
What is Entera Bio annual cash flow from operations?
The current annual CFO of ENTX is -$7.31 M
What is the all time high annual CFO for Entera Bio?
Entera Bio all-time high annual cash flow from operations is -$3.14 M
What is Entera Bio annual CFO year-on-year change?
Over the past year, ENTX annual cash flow from operations has changed by +$5.19 M (+41.52%)
What is Entera Bio quarterly cash flow from operations?
The current quarterly CFO of ENTX is -$2.15 M
What is the all time high quarterly CFO for Entera Bio?
Entera Bio all-time high quarterly cash flow from operations is -$1.33 M
What is Entera Bio quarterly CFO year-on-year change?
Over the past year, ENTX quarterly cash flow from operations has changed by -$292.00 K (-15.68%)
What is Entera Bio TTM cash flow from operations?
The current TTM CFO of ENTX is -$7.97 M
What is the all time high TTM CFO for Entera Bio?
Entera Bio all-time high TTM cash flow from operations is -$2.47 M
What is Entera Bio TTM CFO year-on-year change?
Over the past year, ENTX TTM cash flow from operations has changed by -$405.00 K (-5.36%)